bioRxivCancer Biology
SAMHD1 mutations in mantle cell lymphoma are recurrent and confer in vitro resistance to nucleoside analogues
M. M. Bühler, J. Lu, S. Scheinost, F. Nadeu, D. Roos-Weil, M. Hensel, T. Thavayogarajah, H. Moch, M. G. Manz, E. Haralambieva, E. Marques Maggio, S. Bea, E. Gine, E. Campo, O. A. Bernard, W. Huber, T. Zenz
Abstract
The genomic landscape of mantle cell lymphoma (MCL) includes frequent alterations of TP53, ATM, CCND1 and KMT2D. Thus far, the mutational landscape provides little information for treatment stratification. We characterized a cohort of MCL by targeted next generation sequencing and discovered SAMHD1 as a novel recurrently mutated gene (8.5% of investigated cases, 4/47 samples). Furthermore, we provide evidence of in vitro resistance of SAMHD1 mutated patient-derived MCL cells to cytarabine and fludarabine.
- organism: human
- assay: bulk RNA-seq
- research focus: drug response / drug discovery
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cells
T. Rothenburger, D. Thomas, … J. Cinatl·bioRxiv·Jul 19, 2021
- Coding and regulatory drivers of mantle cell lymphoma identified through exome and genome sequencing
Prasath Pararajalingam, Krysta Mila Coyle, … Ryan D. Morin·BloodPeer-reviewed·Mar 11, 2020
- SAMHD1 is a key regulator of the lineage-specific response of acute lymphoblastic leukaemias to nelarabine
T. Rothenburger, K.-M. McLaughlin, … J. Cinatl·bioRxiv·Dec 3, 2019
- Targeting MCL1-driven anti-apoptotic pathways to overcome hypomethylating agent resistance in RAS-mutated chronic myelomonocytic leukemia
G. Montalban-Bravo, F. Ma, … S. Colla·bioRxiv·Apr 7, 2023
- Functional genomics and tumor microenvironment analysis reveal prognostic biological subtypes in Mantle cell lymphoma
Sunandini Sharma, Roshia Ali, … On behalf of the North American Mantle Cell Lymphoma Project (NAMCLP)·Nature CommunicationsPeer-reviewed·Nov 5, 2025
- Transcription Factor Subtype Governs Response and Resistance to DLL3-Directed T-Cell Engagement in Small Cell Lung Cancer
Damien Vasseur, Shin Saito, … Matthew G. Oser·bioRxiv·Apr 8, 2026